Arlington Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-539
| Closed | -$83.5K | – | 62 |
|
|
2023
Q4 | $83.5K | Buy |
+539
| New | +$83.5K | 0.02% | 112 |
|
|
2023
Q3 | – | Sell |
-4,006
| Closed | -$540K | – | 326 |
|
|
2023
Q2 | $540K | Sell |
4,006
-771
| -16% | -$104K | 0.08% | 79 |
|
|
2023
Q1 | $761K | Buy |
4,777
+2,564
| +116% | +$409K | 0.11% | 63 |
|
|
2022
Q4 | $358K | Sell |
2,213
-1,923
| -46% | -$311K | 0.06% | 73 |
|
|
2022
Q3 | $555K | Sell |
4,136
-263
| -6% | -$35.3K | 0.22% | 55 |
|
|
2022
Q2 | $674K | Buy |
4,399
+671
| +18% | +$103K | 0.22% | 54 |
|
|
2022
Q1 | $604K | Hold |
3,728
| – | – | 0.17% | 59 |
|
|
2021
Q4 | $505K | Buy |
3,728
+254
| +7% | +$34.4K | 0.14% | 70 |
|
|
2021
Q3 | $375K | Buy |
+3,474
| New | +$375K | 0.11% | 72 |
|
|
2020
Q3 | – | Sell |
-42
| Closed | -$4K | – | 138 |
|
|
2020
Q2 | $4K | Sell |
42
-37
| -47% | -$3.52K | ﹤0.01% | 139 |
|
|
2020
Q1 | $6K | Buy |
+79
| New | +$6K | ﹤0.01% | 174 |
|
|
2018
Q4 | – | Sell |
-1,002
| Closed | -$95K | – | 210 |
|
|
2018
Q3 | $95K | Buy |
+1,002
| New | +$95K | 0.07% | 96 |
|